A role for galanin N-terminal fragment (1-15) in anxiety-and depression-related behaviors in Ra

International Journal of Neuropsychopharmacology

Volumn 18, Issue 3, 2015, Pages

  Millón, Carmelo ^a   Flores Burgess, Antonio ^a   Narváez, Manuel ^a   Borroto Escuela, Dasiel O ^b   Santín, Luis ^a   Parrado, Concepción ^a   Narváez, José Angel ^a   Fuxe, Kjell ^b   Díaz Cabiale, Zaida ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anxiety; Depression; Galanin

Indexed keywords

GALANIN 1 15; GALANIN DERIVATIVE; GALANIN RECEPTOR 1; GALANIN RECEPTOR 2; SEROTONIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; GALANIN; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DENTATE GYRUS; DEPRESSION; DORSAL HIPPOCAMPUS; DORSAL RAPHE NUCLEUS; FORCED SWIM TEST; IMMOBILITY; IMMUNOREACTIVITY; LATENT PERIOD; LIGHT-DARK TEST; MALE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; SWIMMING; TAIL SUSPENSION TEST; ANIMAL; ANTAGONISTS AND INHIBITORS; ANXIETY; CHEMICALLY INDUCED; CHEMISTRY; DARK ADAPTATION; DEFICIENCY; DOSE RESPONSE; DRUG EFFECTS; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; METABOLISM; RAPHE NUCLEUS; SPRAGUE DAWLEY RAT; TIME FACTOR; TRANSFORMED CELL LINE; TRANSGENIC RAT;

ANIMALS; ANXIETY; CELL LINE, TRANSFORMED; DARK ADAPTATION; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; GALANIN; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; PEPTIDE FRAGMENTS; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; RECEPTOR, GALANIN, TYPE 1; RECEPTOR, GALANIN, TYPE 2; SEROTONIN; TIME FACTORS;

EID: 85005810484     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyu064     Document Type: Article

References (55)

1. AbdAlla S, Abdel-Baset A, Lother H, el Massiery A, Quitterer U (2005) Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension. J Mol Neurosci 26:185-192.
2. Artigas F (2013) Serotonin receptors involved in antidepressant effects. Pharmacol Ther 137:119-131.
3. Bailey KR, Pavlova MN, Rohde AD, Hohmann JG, Crawley JN (2007) Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specifc to the elevated plus-maze. Pharmacol Biochem Behav 86:8-20.
4. Barr AM, Kinney JW, Hill MN, Lu X, Biros S, Rebek J, Jr., Bartfai T (2006) A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclini-cal tests. Neurosci Lett 405:111-115.
5. Barrera G, Echevarria DJ, Poulin JF, Laforest S, Drolet G, Morilak DA (2005) One for all or one for one: does co-transmission unify the concept of a brain galanin "system" or clarify any consistent role in anxiety? Neuropeptides 39:289-292.
6. Bartfai T, Lu X, Badie-Mahdavi H, Barr AM, Mazarati A, Hua XY, Yaksh T, Haberhauer G, Ceide SC, Trembleau L, Somogyi L, Krock L, Rebek J, Jr. (2004) Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. Proc Natl Acad Sci USA 101:10470-10475.
7. Bellido I, Diaz-Cabiale Z, Jimenez-Vasquez PA, Andbjer B, Mathe AA, Fuxe K (2002) Increased density of galanin binding sites in the dorsal raphe in a genetic rat model of depression. Neu-rosci Lett 317:101-105.
8. Bing O, Moller C, Engel JA, Soderpalm B, Heilig M (1993) Anxio-lytic-like action of centrally administered galanin. Neurosci Lett 164:17-20.
9. Borroto-Escuela DO, Narvaez M, Marcellino D, Parrado C, Nar-vaez JA, Tarakanov AO, Agnati LF, Diaz-Cabiale Z, Fuxe K (2010) Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization. Biochem Biophys Res Com-mun 393:767-772.
10. Borroto-Escuela DO, Romero-Fernandez W, Mudo G, Perez-Alea M, Ciruela F, Tarakanov AO, Narvaez M, Di Liberto V, Agnati LF, Belluardo N, Fuxe K (2012) Fibroblast growth factor receptor 1-5-hydroxytryptamine 1A heteroreceptor complexes and their enhancement of hippocampal plasticity. Biol Psychiatry 71:84-91.
11. Borroto-Escuela DO, Romero-Fernandez W, Garriga P, Ciruela F, Narvaez M, Tarakanov AO, Palkovits M, Agnati LF, Fuxe K (2013) G protein-coupled receptor heterodimerization in the brain. Methods Enzymol 521:281-294.
12. Branchek TA, Smith KE, Gerald C, Walker MW (2000) Galanin receptor subtypes. Trends Pharmacol Sci 21:109-117.
13. Brunner SM, Farzi A, Locker F, Holub BS, Drexel M, Reichmann F, Lang AA, Mayr JA, Vilches JJ, Navarro X, Lang R, Sperk G, Holzer P, Kofer B (2014) GAL3 receptor KO mice exhibit an anxietylike phenotype. Proc Natl Acad Sci USA 111:7138-7143.
14. Desikan A, Wills DN, Ehlers CL (2014) Ontogeny and adolescent alcohol exposure in Wistar rats: open feld confict, light/dark box and forced swim test. Pharmacol Biochem Behav 122:279-285.
15. Diaz-Cabiale Z, Narvaez JA, Finnman UB, Bellido I, Ogren SO, Fuxe K (2000) Galanin-(1-16) modulates 5-HT1A receptors in the ventral limbic cortex of the rat. Neuroreport 11:515-519.
16. Diaz-Cabiale Z, Parrado C, Vela C, Razani H, Covenas R, Fuxe K, Narvaez JA (2005) Role of galanin and galanin(1-15) on central cardiovascular control. Neuropeptides 39:185-190.
17. Diaz-Cabiale Z, Parrado C, Fuxe K, Agnati L, Narvaez JA (2007) Receptor-receptor interactions in central cardiovascular regulation. Focus on neuropeptide/alpha(2)-adrenoreceptor interactions in the nucleus tractus solitarius. J Neural Transm 114:115-125.
18. Diaz-Cabiale Z, Parrado C, Narvaez M, Millon C, Puigcerver A, Fuxe K, Narvaez JA (2010) Neurochemical modulation of central cardiovascular control: the integrative role of galanin. EXS 102:113-131.
19. Diaz-Cabiale Z, Parrado C, Narvaez M, Puigcerver A, Millon C, Santin L, Fuxe K, Narvaez JA (2011) Galanin receptor/Neuro-peptide Y receptor interactions in the dorsal raphe nucleus of the rat. Neuropharmacology 61:80-86.
20. Fuxe K, Marcellino D, Rivera A, Diaz-Cabiale Z, Filip M, Gago B, Roberts DC, Langel U, Genedani S, Ferraro L, de la Calle A, Narvaez J, Tanganelli S, Woods A, Agnati LF (2008) Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res Rev 58:415-452.
21. Fuxe K, Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO, Calvo F, Garriga P, Tena M, Narvaez M, Millon C, Parrado C, Ciruela F, Agnati LF, Narvaez JA, Diaz-Cabiale Z (2012) On the existence and function of galanin receptor heteromers in the central nervous system. Front Endocrinol 3:127.
22. Gelenberg AJ (2010) The prevalence and impact of depression. J Clin Psychiatry 71:e06.
23. Grivas V, Markou A, Pitsikas N (2013) The metabotropic gluta-mate 2/3 receptor agonist LY379268 induces anxiety-like behavior at the highest dose tested in two rat models of anxiety. Eur J Pharmacol 715:105-110.
24. Hedlund PB, Yanaihara N, Fuxe K (1992) Evidence for specifc N-terminal galanin fragment binding sites in the rat brain. Eur J Pharmacol 224:203-205.
25. Hedlund PB, Finnman UB, Yanaihara N, Fuxe K (1994) Gala-nin-(1-15), but not galanin-(1-29), modulates 5-HT1A receptors in the dorsal hippocampus of the rat brain: possible existence of galanin receptor subtypes. Brain Res 634:163-167.
26. Hinojosa FR, Spricigo L, Jr., Izidio GS, Bruske GR, Lopes DM, Ramos A (2006) Evaluation of two genetic animal models in behavioral tests of anxiety and depression. Behav Brain Res 168:127-136.
27. Holmes A, Picciotto MR (2006) Galanin: a novel therapeutic target for depression, anxiety disorders and drug addiction? CNS Neurol Disord Drug Targets 5:225-232.
28. Holmes A, Kinney JW, Wrenn CC, Li Q, Yang RJ, Ma L, Vishwanath J, Saavedra MC, Innerfeld CE, Jacoby AS, Shine J, Iismaa TP, Crawley JN (2003) Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specifc to the elevated plus-maze. Neuropsychopharmacology 28:1031-1044.
29. Jacobowitz DM, Kresse A, Skoftsch G (2004) Galanin in the brain: chemoarchitectonics and brain cartography-a historical review. Peptides 25:433-464.
30. Juhasz G, Hullam G, Eszlari N, Gonda X, Antal P, Anderson IM, Hokfelt TG, Deakin JF, Bagdy G (2014) Brain galanin system genes interact with life stresses in depression-related pheno-types. Proc Natl Acad Sci USA 111:E1666-1673.
31. Kormos V, Gaszner B (2013) Role of neuropeptides in anxiety, stress, and depression: from animals to humans. Neuropep-tides 47:401-419.
32. Kuteeva E, Hokfelt T, Ogren SO (2005) Behavioral characterisation of transgenic mice overexpressing galanin under the PDGF-B promoter. Neuropeptides 39:299-304.
33. Kuteeva E, Wardi T, Hokfelt T, Ogren SO (2007) Galanin enhances and a galanin antagonist attenuates depression-like behavior in the rat. Eur Neuropsychopharmacol 17:64-69.
34. Kuteeva E, Wardi T, Lundstrom L, Sollenberg U, Langel U, Hok-felt T, Ogren SO (2008) Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body level. Neuropsychophar-macology 33:2573-2585.
35. Le Maitre TW, Xia S, Le Maitre E, Dun XP, Lu J, Theodorsson E, Ogren SO, Hokfelt T, Xu ZQ (2011) Galanin receptor 2 over-expressing mice display an antidepressive-like pheno-type: possible involvement of the subiculum. Neuroscience 190:270-288.
36. Lu X, Barr AM, Kinney JW, Sanna P, Conti B, Behrens MM, Bartfai T (2005) A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proc Natl Acad Sci USA 102:874-879.
37. Lu X, Ross B, Sanchez-Alavez M, Zorrilla EP, Bartfai T (2008) Pheno-typic analysis of GalR2 knockout mice in anxiety-and depression-related behavioral tests. Neuropeptides 42:387-397.
38. Lundberg C, Englund U, Trono D, Bjorklund A, Wictorin K (2002) Differentiation of the RN33B cell line into forebrain projection neurons after transplantation into the neonatal rat brain. Exp Neurol 175:370-387.
39. Mitsukawa K, Lu X, Bartfai T (2008) Galanin, galanin receptors and drug targets. Cell Mol Life Sci 65:1796-1805.
40. Moller C, Sommer W, Thorsell A, Heilig M (1999) Anxiogenic-like action of galanin after intra-amygdala administration in the rat. Neuropsychopharmacology 21:507-512.
41. Morilak DA, Cecchi M, Khoshbouei H (2003) Interactions of nor-epinephrine and galanin in the central amygdala and lateral bed nucleus of the stria terminalis modulate the behavioral response to acute stress. Life Sci 73:715-726.
42. Nakajima H, Kubo T, Semi Y, Itakura M, Kuwamura M, Izawa T, Azuma YT, Takeuchi T (2012) A rapid, targeted, neuron-selective, in vivo knockdown following a single intracerebroven-tricular injection of a novel chemically modifed siRNA in the adult rat brain. J Biotechnol 157:326-333.
43. Narvaez M, Millon C, Borroto-Escuela D, Flores-Burgess A, Santin L, Parrado C, Gago B, Puigcerver A, Fuxe K, Narvaez JA, Diaz-Cabiale Z (2014) Galanin receptor 2-neuropeptide Y Y1 receptor interactions in the amygdala lead to increased anxiolytic actions. Brain Struct Funct. doi:10.1007/s00429-014-0788-7
44. O'Donnell D, Ahmad S, Wahlestedt C, Walker P (1999) Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J Comp Neurol 409:469-481.
45. Parrado C, Diaz-Cabiale Z, Garcia-Coronel M, Agnati LF, Covenas R, Fuxe K, Narvaez JA (2007) Region specifc galanin receptor/neuropeptide Y Y1 receptor interactions in the tel-and dien-cephalon of the rat. Relevance for food consumption. Neu-ropharmacology 52:684-692.
46. Paxinos GWC (1986) The rat brain in stereotaxic coordinates. New York: Academic Press.
47. Picciotto MR (2010) Galanin and addiction. EXS 102:195-208.
48. Swanson CJ, Blackburn TP, Zhang X, Zheng K, Xu ZQ, Hokfelt T, Wolinsky TD, Konkel MJ, Chen H, Zhong H, Walker MW, Craig DA, Gerald CP, Branchek TA (2005) Anxiolytic-and antide-pressant-like profles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc Natl Acad Sci USA 102:17489-17494.
49. Tatemoto K, Rokaeus A, Jornvall H, McDonald TJ, Mutt V (1983) Galanin-a novel biologically active peptide from porcine intestine. FEBS Lett 164:124-128.
50. Triflieff P, Rives ML, Urizar E, Piskorowski RA, Vishwasrao HD, Castrillon J, Schmauss C, Slattman M, Gullberg M, Javitch JA (2011) Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum. Biotechniques 51:111-118.
51. Wang S, Hashemi T, He C, Strader C, Bayne M (1997) Molecular cloning and pharmacological characterization of a new gala-nin receptor subtype. Mol Pharmacol 52:337-343.
52. Weiss JM, Bonsall RW, Demetrikopoulos MK, Emery MS, West CH (1998) Galanin: a signifcant role in depression? Ann NY Acad Sci 863:364-382.
53. Wirz SA, Davis CN, Lu X, Zal T, Bartfai T (2005) Homodimerization and internalization of galanin type 1 receptor in living CHO cells. Neuropeptides 39:535-546.
54. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:655-679.
55. Yan Y, Wang YL, Su Z, Zhang Y, Guo SX, Liu AJ, Wang CH, Sun FJ, Yang J (2014) Effect of oxytocin on the behavioral activity in the behavioral despair depression rat model. Neuropeptides 48:83-89.